Catalyst Wire Dossier Catalyst Wire Dossier

CD07805/47 Topical Gel

CD07805/47 topical gel · Galderma R&D
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for CD07805/47 Topical Gel, covering 2013-11-21 to 2014-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema [Phase 3]

See pricing